Date	Period	Revenue/Estimate	Earnings Call
Dec 13, 2024	2025/Q1	4.230B / --	--
Jun 13, 2024	2024/Q3	4.790B / 5.051B	--
Mar 14, 2024	2024/Q2	5.385B / 6.036B	--
Dec 14, 2023	2024/Q1	5.264B / 6.100B	--
Sep 14, 2023	2023/Q4	5.791B / 5.890B	--

DatePeriodRevenue/EstimateEarnings Call

Dec 13, 20242025/Q14.230B / ----

Jun 13, 20242024/Q34.790B / 5.051B--

Mar 14, 20242024/Q25.385B / 6.036B--

Dec 14, 20232024/Q15.264B / 6.100B--

Sep 14, 20232023/Q45.791B / 5.890B--

Unlock Free Earnings Estimates

Open Account

Premier Anti-Aging: Presentation of financial results for the 1st quarter of the fiscal year ending July 2025

Dec 13 01:30 ET

Premier Anti-Aging: Summary of Financial Results for the 1st Quarter Ending July 2025 [Japanese GAAP] (Consolidated)

Dec 13 01:30 ET

Premier Anti-Aging: Interim Report of Corrections

Nov 13 03:00 ET

Premier Anti-Aging: Interim report

Oct 30 02:02 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Dec 26, 2024

Hold

No Data